OPPORTUNITY RADAR SCREENER COMPARE ANY 2 STOCKS

EARNINGS CALL ARCHIVE 1 CALL ON FILE

BDRX — Biodexa Pharmaceuticals Plc

NASDAQ

FULL STOCK PAGE →

Q2 2021 Earnings Call Summary

SEP 20, 2021

REVENUE

$401000 +129.1%

NET MARGIN

-786.5% +1938.6 PTS

EPS

-$3460030.00 +29.9%

FREE CASH FLOW

-$3.3M -41.3%

No summary has been written for this call yet.